Actuate Therapeutics, Inc. Common stock (ACTU) Stock Price, Quote & AI Analysis
Live ACTU stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Actuate Therapeutics, Inc. Common stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Actuate Therapeutics, Inc. Common stock (ACTU), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Actuate Therapeutics, Inc. Common stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Actuate Therapeutics, Inc. Common stock Overview
Company information
Company Overview
Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Actuate Therapeutics, Inc. Common stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...